Market Overview-
With the rise in the global autism disorder
& treatment market, there are several barriers faced by the market players such
as a weak pipeline of drugs for autism disorder and unknown etiology and
pathophysiology of ASD. According to a report published by Market Research
future (MRFR), global autism
disorder & treatment market share is expected to grow at a 4.4% CAGR during
the forecast period 2023 to 2032. The market is estimated to witness
significant growth due to the growing acceptance and awareness about global autism
disorder among individuals and the improvement in treatment methods for the
safety and secure lives of the individuals diagnosed with autism. Additionally,
the growing environmental imbalances are also considered to be a factor causing
the increasing prevalence of autism disorders.
Autism Spectrum Disorder (ASD) is an array
of conditions caused by challenges in speech, social skills, and repetitive
behaviors, nonverbal communication, along with unique strengths and
differences. This condition is primarily caused by special combinations of
genetic and environmental influences. Autism tends to show its most common
signs between two and three years of age and can often be diagnosed within 18
months of the child’s birth.
The global autism disorder and treatment
market has been accounted as one of the rapidly growing industries, due to
rising prevalence of autism and Pervasive Developmental Disorder (PDD) and raising
awareness regarding autism among the patients. Autism disorder and treatment
market insights is observed as one of the steadily growing markets in the
healthcare sector because of government initiatives taken by the various
nations and anticipated approvals of various off-label treatment therapy measures
by the Food and Drug Association (FDA).
Key
Players
global autism disorder & treatment
market players are Johnson & Johnson Services, Inc., Pfizer Inc., Eli Lilly,
and Company, Merck & CO Inc., Allergan, Saniona AB, Consern Pharma Private
Limited, Teva Pharmaceutical Industries Ltd.,Novartis AG, Bristol-Myers Squibb
and Otsuka Holdings Co., Ltd., Coronis Partners Ltd., Intra-Cellular Therapies
Inc., Heptares Therapeutics Limited, Curemark LLC, and few others.
segmental
analysis
The Global autism
disorder & treatment market outlook has been segmented based on type,
treatment type, and drugs. Based on type, it is segmented into Asperger
Syndrome, Pervasive Developmental Disorder, and others.Based on treatment type,
it is segmented into ABA (applied behavioral analysis), hyperbaric oxygen
therapy, chelation therapy, oxytocin therapy, and others. Based on the drug, it
is segmented into SSRIs, anti-convulsant, stimulants, anti-psychotic.
Anti-psychotics are segmented into Abilify (aripiprazole) and Risperidone.
Based on the region, the market has been segmented into North America, Europe,
Asia Pacific, and middle east and Africa.
Regional
Analysis
North America has been accounted for the
largest market owing to the increase in a number of autism cases in this
region. Additionally, the approval and anticipated launch of the atypical
anti-psychotic such as Latuda and Namenda is projected to generate increased
sales in the U.S. North America is estimated to witness significant growth over
the forecast period. The Asia Pacific region is anticipated to be the fastest
growing market while the Middle East & Africa show steady and growth during
the forecast period. Some of the influential factors responsible for the
increasing healthcare facilities in the global autism disorder & treatment
market are the expansion of diagnostic criteria, improved awareness, better
diagnostic tools, and improved reporting. APAC and Middle and Africa region has
started accepting the global autism disorder & treatment market fairly
recently due to the lack of awareness in the past years about the disorders,
but are estimated to show significant growth due to growing awareness among the
consumers.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
